TL;DR
This study provides the first comprehensive global analysis of bla<sub>NDM-9</sub>-carrying carbapenem-resistant Escherichia coli (CREC), revealing that Asia, particularly China, is a major hub for these strains. The research highlights the critical role of mobile genetic elements like IS26 and ISCR1 in spreading the resistance gene and identifies ST156 as a globally prevalent lineage, underscoring the urgent need for intensified surveillance.
What Problem Does This Paper Address?
Carbapenem-resistant Escherichia coli (CREC) strains producing the New Delhi metallo-β-lactamase-9 (NDM-9) enzyme are a growing threat in healthcare settings, causing difficult-to-treat nosocomial infections. Despite their emergence in 2013, a comprehensive understanding of their global spread, genetic makeup, and transmission pathways has been lacking. This gap makes it challenging to develop effective strategies for containment and control. The paper aims to fill this void by providing a detailed global phylogeographic and genomic analysis of bla<sub>NDM-9</sub>-carrying CREC.
Methods
The study employed a multi-pronged approach:
- Clinical Surveillance: Seven bla<sub>NDM-9</sub>-carrying CREC strains were collected from a tertiary hospital in China over a seven-year period (2018-2024).
- Antimicrobial Susceptibility Testing (AST): Standard AST was performed to determine resistance profiles.
- Conjugative Transfer Experiments: These experiments assessed the ability of the resistance plasmids to transfer between bacterial strains.
- Whole-Genome Sequencing (WGS): WGS was used to fully characterize the genomes of the isolated strains, identifying resistance genes, plasmid types, and genetic diversity.
- Global Data Integration: Publicly available bla<sub>NDM-9</sub>-carrying CREC genomes from NCBI were integrated for a broader global analysis.
- Phylogenetic and Phylogeographic Analysis: Phylogenetic trees were constructed to understand the evolutionary relationships between strains, and geographic data was used to map their global distribution and temporal spread.
- Fitness Analysis: The study evaluated the fitness cost associated with carrying the bla<sub>NDM-9</sub>-carrying plasmids in a recipient E. coli strain.
Datasets
The study utilized two primary sources of data:
- In-house Isolates: Seven bla<sub>NDM-9</sub>-carrying CREC strains collected from a tertiary hospital in China between 2018 and 2024.
- Publicly Available Genomes: A dataset of 203 bla<sub>NDM-9</sub>-carrying CREC genomes downloaded from the NCBI Genome Database (as of July 2025). This dataset was curated to remove duplicate and incomplete genomes.
Key Insights and Ideas
- Asia as a Hotspot: The study strongly implicates Asia, and specifically China, as the primary origin and current hub for bla<sub>NDM-9</sub>-carrying CREC, with over 85% of global isolates originating from China.
- Mobile Elements as Key Drivers: Mobile genetic elements, particularly IS26 and ISCR1, are identified as crucial facilitators of bla<sub>NDM-9</sub> dissemination, highlighting their role in horizontal gene transfer.
- ST156: A Global Lineage: The sequence type ST156 emerged as the most prevalent lineage globally among bla<sub>NDM-9</sub>-carrying CREC, suggesting its successful adaptation and spread.
- Shift from Animal to Human Sources: While chicken isolates were initially dominant, there's a notable recent shift towards human sources, indicating evolving transmission dynamics and potential interspecies jumps.
- Fitness Cost of Resistance: Carrying the bla<sub>NDM-9</sub> plasmid imposes a measurable fitness cost on the host bacteria, suggesting that antibiotic pressure may be necessary for its sustained dominance in clinical settings.
- Intra-hospital Persistence: The analysis of plasmid evolution suggests potential for intra-hospital persistence and spread of specific plasmid types, like the IncB/O/K/Z, within healthcare facilities.
Key Results
- Global Distribution: Out of 203 analyzed isolates, 85.2% were from Asia (primarily China), with smaller proportions from Europe and North America.
- Prevalent Sequence Type: ST156 accounted for 20.1% of the global isolates.
- Primary Sources: Human isolates constituted 39.4%, and chicken isolates 34.9%. A shift towards human predominance was observed since 2016.
- Plasmid Diversity: Diverse plasmid types (IncB/O/K/Z, IncHI2, IncFIB, and IncC) were identified carrying bla<sub>NDM-9</sub>.
- Fitness Burden: Transconjugants carrying bla<sub>NDM-9</sub> plasmids showed significantly reduced growth rates compared to the recipient strain.
- Antibiotic Resistance: All seven clinical isolates were resistant to most tested antimicrobials, except colistin.
Limitations and Future Work
- Sequencing Resource Bias: The authors acknowledge that sequencing resources are heavily biased towards a few countries, potentially limiting a complete understanding of epidemiological trends in low- and middle-income countries.
- Need for Intensified Surveillance: The study strongly advocates for intensified global surveillance, particularly using WGS, to better understand transmission dynamics and public health risks.
- Experimental Evolution: Future research should focus on experimental evolution models to unravel adaptive mechanisms that might counteract the fitness cost of plasmids.
- One Health Approach: The paper emphasizes the need for a "One Health" perspective, integrating human, animal, and environmental health surveillance to combat antimicrobial resistance.
- Therapeutic Alternatives: The limited therapeutic options for high-risk clones like ST156 highlight the critical need for developing novel treatment strategies.
Summary updated